Eudenilson L Albuquerque

6PUBLICATIONS
10CO-AUTHORS
Biomolecular modelling and designInstrumental methods (excl. immunological and bioassay methods)Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Dec 07, 2023
In silico description of the adsorption of cell signaling pathway proteins ovalbumin, glutathione, LC3, TLR4, ASC PYCARD, PI3K and NF-Kβ on 7.0 nm gold nanoparticles: obtaining their Lennard-Jones-like potentials through docking and molecular mechanics.

Monique M Coelho, Eveline M Bezerra, Roner F da Costa

|Nov 02, 2022
Losartan as an ACE inhibitor: a description of the mechanism of action through quantum biochemistry.

Eveline M Bezerra, Érika C de Alvarenga, Ricardo P Dos Santos

|Sep 17, 2021
Blockade of the checkpoint PD-1 by its ligand PD-L1 and the immuno-oncological drugs pembrolizumab and nivolumab.

Ana Beatriz M L A Tavares, J X Lima Neto, U L Fulco

|Jul 15, 2021
Quantum binding energies of checkpoint CTLA-4 in complex with the immuno-oncological drug ipilimumab.

Ana Beatriz M L A Tavares, E L Albuquerque

|Aug 23, 2019
Binding energies of the drugs capreomycin and streptomycin in complex with tuberculosis bacterial ribosome subunits.

Jessica F Vianna, Katyanna S Bezerra, Jonas I N Oliveira

|Feb 01, 2018
Inhibition of the checkpoint protein PD-1 by the therapeutic antibody pembrolizumab outlined by quantum chemistry.

Ana Beatriz M L A Tavares, José X Lima Neto, Umberto L Fulco

Pageof 1

Frequent Collaborators

3 joint publications

Umberto L Fulco

2 joint publications

José X Lima Neto

2 joint publications

Eveline M Bezerra

2 joint publications

Érika C de Alvarenga